Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.

TitleGenotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.
Publication TypeJournal Article
Year of Publication2012
AuthorsBarral S, Bird T, Goate A, Farlow MR, Diaz-Arrastia R, Bennett DA, Graff-Radford N, Boeve BF, Sweet RA, Stern Y, Wilson RS, Foroud T, Ott J, Mayeux R
Corporate AuthorsNational Institute on Aging Late-Onset Alzheimer's Disease Genetics Study
JournalNeurology
Volume78
Issue19
Pagination1464-71
Date Published2012 May 08
ISSN1526-632X
KeywordsAdaptor Proteins, Signal Transducing, Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Clusterin, Female, Genetic Predisposition to Disease, Genome-Wide Association Study, Genotype, Humans, Male, Memory, Episodic, Middle Aged, Monomeric Clathrin Assembly Proteins, Neuropsychological Tests, Nuclear Proteins, Polymorphism, Single Nucleotide, Receptors, Complement 3b, Tumor Suppressor Proteins
Abstract

OBJECTIVE: Several genome-wide association studies (GWAS) have associated variants in late-onset Alzheimer disease (LOAD) susceptibility genes; however, these single nucleotide polymorphisms (SNPs) have very modest effects, suggesting that single SNP approaches may be inadequate to identify genetic risks. An alternative approach is the use of multilocus genotype patterns (MLGPs) that combine SNPs at different susceptibility genes.METHODS: Using data from 1,365 subjects in the National Institute on Aging Late-Onset Alzheimer's Disease Family Study, we conducted a family-based association study in which we tabulated MLGPs for SNPs at CR1, BIN1, CLU, PICALM, and APOE. We used generalized estimating equations to model episodic memory as the dependent endophenotype of LOAD and the MLGPs as predictors while adjusting for sex, age, and education.RESULTS: Several genotype patterns influenced episodic memory performance. A pattern that included PICALM and CLU was the strongest genotypic profile for lower memory performance (β = -0.32, SE = 0.19, p = 0.021). The effect was stronger after addition of APOE (p = 0.016). Two additional patterns involving PICALM, CR1, and APOE and another pattern involving PICALM, BIN1, and APOE were also associated with significantly poorer memory performance (β = -0.44, SE = 0.09, p = 0.009 and β = -0.29, SE = 0.07, p = 0.012) even after exclusion of patients with LOAD. We also identified genotype pattern involving variants in PICALM, CLU, and APOE as a predictor of better memory performance (β = 0.26, SE = 0.10, p = 0.010).CONCLUSIONS: MLGPs provide an alternative analytical approach to predict an individual's genetic risk for episodic memory performance, a surrogate indicator of LOAD. Identifying genotypic patterns contributing to the decline of an individual's cognitive performance may be a critical step along the road to preclinical detection of Alzheimer disease.

DOI10.1212/WNL.0b013e3182553c48
Alternate JournalNeurology
PubMed ID22539578
PubMed Central IDPMC3345618
Grant ListP30AG012300 / AG / NIA NIH HHS / United States
P50AG016570 / AG / NIA NIH HHS / United States
P50AG05134 / AG / NIA NIH HHS / United States
P30AG028383 / AG / NIA NIH HHS / United States
P50AG005133 / AG / NIA NIH HHS / United States
U24AG26396 / AG / NIA NIH HHS / United States
P50AG016582 / AG / NIA NIH HHS / United States
U24 AG021886 / AG / NIA NIH HHS / United States
U01 AG032984 / AG / NIA NIH HHS / United States
P30AG08017 / AG / NIA NIH HHS / United States
P50AG8702 / AG / NIA NIH HHS / United States
R01 AG017917 / AG / NIA NIH HHS / United States
R01AG17917 / AG / NIA NIH HHS / United States
P50AG05142 / AG / NIA NIH HHS / United States
P30AG010124 / AG / NIA NIH HHS / United States
U24AG021886 / AG / NIA NIH HHS / United States
P50AG016574 / AG / NIA NIH HHS / United States
R01AG027224 / AG / NIA NIH HHS / United States
P30AG013846 / AG / NIA NIH HHS / United States
U24 AG026395 / AG / NIA NIH HHS / United States
P30AG010133 / AG / NIA NIH HHS / United States
P50AG05136 / AG / NIA NIH HHS / United States
P50 AG005133 / AG / NIA NIH HHS / United States
R01 AG041797 / AG / NIA NIH HHS / United States
R01 AG027224 / AG / NIA NIH HHS / United States
P30AG10161 / AG / NIA NIH HHS / United States
P30AG013854 / AG / NIA NIH HHS / United States
R01 AG036040 / AG / NIA NIH HHS / United States
P50AG05681 / AG / NIA NIH HHS / United States
P30AG028377 / AG / NIA NIH HHS / United States
R01 AG015819 / AG / NIA NIH HHS / United States
P50AG05138 / AG / NIA NIH HHS / United States